{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:05:58Z","timestamp":1789909558899,"version":"4.0.1"},"reference-count":10,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sexually Transmitted Infections"],"published-print":{"date-parts":[[1993,4,1]]},"DOI":"10.1136\/sti.69.2.91","type":"journal-article","created":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T21:44:35Z","timestamp":1226526275000},"page":"91-93","source":"Crossref","is-referenced-by-count":2,"title":["Recurrence of condylomata acuminata following cryotherapy is not prevented by systemically administered interferon."],"prefix":"10.1136","volume":"69","author":[{"given":"L J","family":"Eron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M B","family":"Alder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"O'Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Rittweger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"DePamphilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J","family":"Pizzuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1056\/NEJM198610233151704","article-title":"Interferon therapy for condylomata acuminata","volume":"315","author":"Eron, L.J.; Judson, F.; Tucker, S.","year":"1986","unstructured":"Eron LJ, Judson F, Tucker S, et al. Interferon therapy for condylomata acuminata. N Etngl J Med 1986;315: 1059-64.","journal-title":"N Etngl J Med"},{"key":"ref_2","first-page":"172","article-title":"Intralesional and recombinant alpha-2 interferon for the treatment of patients with condylomata acuminata or verruca plantaris","volume":"122","author":"Vance, J.C.; Bart, B.J.; Hansen, R.C.","year":"1986","unstructured":"Vance JC, Bart BJ, Hansen RC, et al. Intralesional and recombinant alpha-2 interferon for the treatment of patients with condylomata acuminata or verruca plantaris. Arch Derrnatol 1986;122:172-7.","journal-title":"Arch Derrnatol"},{"issue":"184","key":"ref_3","first-page":"331","article-title":"The effect of asymptomatic infection with HTLV-III on the response of anogenital warts to intralesional treatment with recombinant a-2 interferon","volume":"1986","author":"Douglas, J.M.; Rogers, M.; Judson, F.N.","unstructured":"Douglas JM, Rogers M, Judson FN. The effect of asymptomatic infection with HTLV-III on the response of anogenital warts to intralesional treatment with recombinant a-2 interferon. _l Infect Dis 1986:184:331-4.","journal-title":"_l Infect Dis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/infdis\/162.6.1270","article-title":"Treatment of condyloma acuminatum with three different interferonalpha preparations administered parenterally in a double-blind, placebo-controlled trial","volume":"162","author":"Reichman, R.C.; Oakes, D.; Bonnez, W.","year":"1990","unstructured":"Reichman RC, Oakes D, Bonnez W, et al. Treatment of condyloma acuminatum with three different interferonalpha preparations administered parenterally in a double-blind, placebo-controlled trial. J Infect Dis 1990;162: 1270-6.","journal-title":"J Infect Dis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jama.1988.03720040025021","article-title":"Natural interferon alpha for treatment of condylomata acuminata","volume":"259","author":"Friedman-Kien, A.E.; Eron, U.; Conant, M.","year":"1988","unstructured":"Friedman-Kien AE, Eron U, Conant M, et al. Natural interferon alpha for treatment of condylomata acuminata. JAMA 1988;259:533-8.","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-4362.1985.tb05557.x","article-title":"Cryotherapy vs podophyllin in the treatment of genital warts","volume":"24","author":"Bashi, S.A.","year":"1985","unstructured":"Bashi SA. Cryotherapy vs podophyllin in the treatment of genital warts. IntJ Dermatol 1985;24:535-6.","journal-title":"IntJ Dermatol"},{"key":"ref_7","first-page":"297","article-title":"Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomised observer blind placebo controlled study","volume":"67","author":"Handley, J.M.; Homer, T.; Maw, R.D.","year":"1991","unstructured":"Handley JM, Homer T, Maw RD, et al. Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomised observer blind placebo controlled study. Genitourin Med 1991;67:297-302.","journal-title":"Genitourin Med"},{"key":"ref_8","first-page":"815","article-title":"Surgical debulking is enhanced by adjuvant systemic interferon","volume":"166","author":"Reid, R.; Greenberg, M.D.; Pizzuti, D.J.","year":"1992","unstructured":"Reid R, Greenberg MD, Pizzuti DJ, et al. Superficial laser vulvectomy. V. Surgical debulking is enhanced by adjuvant systemic interferon. Ani 7 Obstet Gynecol 1992; 166:815-20.","journal-title":"Ani 7 Obstet Gynecol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/1523-1747.ep12875118","article-title":"Interferon alpha-2b injections used as an adjuvant therapy to carbon dioxide laser vaporisation of recalcitrant anogenital condylomata acuminata","volume":"95","author":"Vance, J.C.; Davis, D.","year":"1990","unstructured":"Vance JC, Davis D. Interferon alpha-2b injections used as an adjuvant therapy to carbon dioxide laser vaporisation of recalcitrant anogenital condylomata acuminata. Jf Invest Dernatol 1990;95: 146S-8S.","journal-title":"Jf Invest Dernatol"},{"key":"ref_10","first-page":"99","article-title":"Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled study","volume":"67","author":"Petersen, C.S.; Bjerring, P.; Larsen, J.","year":"1991","unstructured":"Petersen CS, Bjerring P, Larsen J, et al. Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled study. Genitourin Med 1991;67: 99-102.","journal-title":"Genitourin Med"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T23:52:30Z","timestamp":1601077950000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sti.69.2.91"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,4,1]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/sti.69.2.91","relation":{},"ISSN":["1368-4973"],"issn-type":[{"value":"1368-4973","type":"print"}],"subject":[],"published":{"date-parts":[[1993,4,1]]}}}